Nishino Masanori, Ikegami Hiroshi, Fujisawa Tomomi, Kawaguchi Yoshihiko, Kawabata Yumiko, Shintani Maki, Ono Masaya, Ogihara Toshio
Department of Geriatric Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.
Metabolism. 2005 May;54(5):628-33. doi: 10.1016/j.metabol.2004.12.006.
The association of the polymorphism of the Z-DNA-forming repeats in the promoter region of SLC11A1 (solute carrier family 11 member 1), formerly designated NRAMP1 (natural resistance associated macrophage protein 1), with type 1 diabetes was studied in a total of 244 Japanese subjects. Three alleles were detected in Japanese subjects. In diabetic patients, allele 2 was less frequent and allele 3 was more frequent, albeit not significantly, than in control subjects. Allele 2 was significantly ( P < .024) less frequent whereas allele 3 was more, albeit not significantly, frequent in the younger onset group than in the control subjects. In patients with a susceptible HLA allele, DRB10405 or DRB10901 , the frequency of allele 2 was significantly ( P < .013) lower and that of allele 3 tended to be higher than that in patients without either DRB10405 or DRB10901 . The protective effect of allele 2 against type 1 diabetes and other autoimmune diseases was confirmed by meta-analysis (summary odds ratio, 0.71, 95% confidence interval, 0.53-0.96). Because allele 2 was shown to be associated with low expression of SLC11A1 and protection against another autoimmune disease, rheumatoid arthritis, the negative association of allele 2 with autoimmune type 1 diabetes in the present study suggests that a less active immune system in subjects with allele 2 may protect individuals from autoimmune diseases.
在总共244名日本受试者中,研究了溶质载体家族11成员1(SLC11A1)(以前称为天然抵抗相关巨噬细胞蛋白1,NRAMP1)启动子区域中形成Z-DNA的重复序列多态性与1型糖尿病的关联。在日本受试者中检测到三个等位基因。在糖尿病患者中,与对照组相比,等位基因2的频率较低,等位基因3的频率较高,尽管差异不显著。在发病年龄较小的组中,等位基因2的频率显著低于对照组(P <.024),而等位基因3的频率较高,尽管差异不显著。在携带易感HLA等位基因DRB10405或DRB10901的患者中,等位基因2的频率显著低于(P <.013)且等位基因3的频率倾向于高于不携带DRB10405或DRB10901的患者。通过荟萃分析证实了等位基因2对1型糖尿病和其他自身免疫性疾病的保护作用(汇总比值比,0.71,95%置信区间,0.53 - 0.96)。由于等位基因2与SLC11A1的低表达以及对另一种自身免疫性疾病类风湿关节炎的保护作用相关,本研究中等位基因2与自身免疫性1型糖尿病的负相关表明,携带等位基因2的个体免疫系统活性较低,可能使其免受自身免疫性疾病的影响。